Chia-Chi Lin

20PUBLICATIONS
112CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Pharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 08, 2026
First-in-human, phase 1, open-label study of alomfilimab, an anti-ICOS antibody, as a single agent and in combination with anti-PD-L1 in advanced malignancies.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Mar 09, 2026
First-in-human phase 1 study of RO7119929, an oral TLR7 agonist prodrug, in patients with advanced primary or metastatic liver cancers.

Changhoon Yoo, Carles Fabregat-Franco, Chia-Chi Lin

|Apr 24, 2025
Barriers to publishing early phase clinical trials: the oncologists' perspective.

Merel J J Lucassen, Pedro Bergmann, Olga Husson

|Apr 22, 2025
Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors.

Nai-Jung Chiang, Jih-Hsiang Lee, Ming-Huang Chen

|Jan 06, 2025
Passing the Torch forward: Moving beyond EGFR Inhibition in NMIBC Prevention.

Tsung-Che Wu, Chia-Chi Lin

Pageof 4

Frequent Collaborators

4 joint publications

Yung-Jue Bang

3 joint publications

Toshio Shimizu

3 joint publications

Victor Moreno

2 joint publications

Noboru Yamamoto